Linfu Chen

2.1k total citations · 2 hit papers
38 papers, 1.6k citations indexed

About

Linfu Chen is a scholar working on Biomedical Engineering, Molecular Biology and Immunology. According to data from OpenAlex, Linfu Chen has authored 38 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Biomedical Engineering, 11 papers in Molecular Biology and 11 papers in Immunology. Recurrent topics in Linfu Chen's work include Nanoplatforms for cancer theranostics (15 papers), Cancer Research and Treatments (10 papers) and Inhalation and Respiratory Drug Delivery (7 papers). Linfu Chen is often cited by papers focused on Nanoplatforms for cancer theranostics (15 papers), Cancer Research and Treatments (10 papers) and Inhalation and Respiratory Drug Delivery (7 papers). Linfu Chen collaborates with scholars based in China, Australia and Macao. Linfu Chen's co-authors include Zhuang Liu, Qian Chen, Yang Yang, Maoyi Li, Wenjun Zhu, Qiufang Chen, Jun Zhou, Xinjie Li, Ziliang Dong and Jingjing Shen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Nature Communications.

In The Last Decade

Linfu Chen

36 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery

2022 452 citations Jun Zhou, Maoyi Li et al. Nature Communications profile →
Bioactive Layered Double Hydroxides for Synergistic Sonodynamic/Cuproptosis Anticancer Therapy with Elicitation of the Immune Response

2024 83 citations Linfu Chen, Zhihui Han et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Linfu Chen China	22	628	508	259	242	174	38	1.6k
Qi‐Wen Chen China	21	827 1.3×	389 0.8×	216 0.8×	390 1.6×	134 0.8×	66	1.6k
Jiaqi Xu China	16	855 1.4×	812 1.6×	371 1.4×	199 0.8×	363 2.1×	30	1.9k
Hee Ho Park South Korea	21	362 0.6×	719 1.4×	390 1.5×	148 0.6×	360 2.1×	63	1.7k
Venkata Vamsi Krishna Venuganti India	29	368 0.6×	745 1.5×	454 1.8×	157 0.6×	291 1.7×	71	2.6k
Huiting Zhou China	18	474 0.8×	534 1.1×	376 1.5×	229 0.9×	254 1.5×	58	1.8k
Chenwen Li China	23	533 0.8×	457 0.9×	623 2.4×	301 1.2×	180 1.0×	46	1.8k
María de la Fuente Spain	28	423 0.7×	1.4k 2.7×	580 2.2×	154 0.6×	247 1.4×	92	2.9k
Jiacai Yang China	24	504 0.8×	471 0.9×	196 0.8×	450 1.9×	481 2.8×	45	2.0k

Countries citing papers authored by Linfu Chen

Since Specialization

Citations

This map shows the geographic impact of Linfu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linfu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linfu Chen more than expected).

Fields of papers citing papers by Linfu Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linfu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linfu Chen. The network helps show where Linfu Chen may publish in the future.

Co-authorship network of co-authors of Linfu Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Linfu Chen. A scholar is included among the top collaborators of Linfu Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linfu Chen. Linfu Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Lin, Xu Chen, Xiaojing Lu, et al.. (2025). Gambogic Acid Based Coordination Polymer Reinforces High‐Intensity Focused Ultrasound Treatment of Gynecologic Malignancies. Advanced Materials. 37(26). e2501664–e2501664. 2 indexed citations

Chen, Zhike, Weibiao Zeng, Linfu Chen, et al.. (2025). Inhalable myofibroblast targeting nanoparticles for synergistic treatment of pulmonary fibrosis. Science Advances. 11(18). eadv9571–eadv9571. 4 indexed citations

Lu, Shunyi, Yuqi Yang, Jie Cao, et al.. (2025). Dual functional nanoplatforms potentiate osteosarcoma immunotherapy via microenvironment modulation. National Science Review. 12(3). nwaf002–nwaf002. 9 indexed citations

Yu, Miao, Hanlin Zhang, Cheng Wang, et al.. (2025). Inhalable Nanovaccine Based on Bioengineered Bacteria‐Derived Membrane Vesicles Against Lung Metastasis. Advanced Materials. 38(3). e06174–e06174.

Yu, Qian, Qiang Zhang, Jiafei Zhu, et al.. (2025). Inhalable neutrophil-mimicking nanoparticles for chronic obstructive pulmonary disease treatment. Journal of Controlled Release. 381. 113648–113648. 4 indexed citations

Lv, Xinying, Jingjing Shen, Qiang Zhang, et al.. (2025). The Optimized Lipid‐Modified Prodrug for CNV Treatment. Advanced Materials. 37(10). e2419263–e2419263.

Fang, Huapan, Lin Zhang, Linfu Chen, et al.. (2024). Carrier-free multifunctional nanomedicine for enhanced hyperthermic intraperitoneal chemotherapy against abdominal pelvic tumors. Chemical Engineering Journal. 498. 155781–155781. 6 indexed citations

Yang, Yuqi, Jun Ge, Xiaoyan Zhong, et al.. (2024). Turning Waste into Wealth: A Potent Sono‐Immune Strategy Based on Microcystis. Advanced Materials. 36(33). e2401974–e2401974. 14 indexed citations

Li, Maoyi, Nanhui Liu, Jiafei Zhu, et al.. (2024). Engineered probiotics with sustained release of interleukin-2 for the treatment of inflammatory bowel disease after oral delivery. Biomaterials. 309. 122584–122584. 41 indexed citations

10.

Shen, Jingjing, Linfu Chen, Xinying Lv, et al.. (2024). Emerging Co‐Assembled and Sustained Released Natural Medicinal Nanoparticles for Multitarget Therapy of Choroidal Neovascularization. Advanced Materials. 36(23). e2314095–e2314095. 24 indexed citations

11.

Zhang, Lin, Xiaoyan Gao, Yaru Sheng, et al.. (2024). pH‐Responsive and Therapeutic Liposomes for Enhanced High‐Intensity Focused Ultrasound Imaging and Therapy in Gynecologic Malignancies. Advanced Functional Materials. 35(5). 1 indexed citations

12.

Chen, Linfu, Jingjing Shen, Miao Yu, et al.. (2024). An emerging antibacterial nanovaccine for enhanced chemotherapy by selectively eliminating tumor-colonizing bacteria. Science Bulletin. 69(16). 2565–2579. 33 indexed citations

13.

Chen, Linfu, Rui Zhao, Jingjing Shen, et al.. (2023). Antibacterial Fusobacterium nucleatum‐Mimicking Nanomedicine to Selectively Eliminate Tumor‐Colonized Bacteria and Enhance Immunotherapy Against Colorectal Cancer. Advanced Materials. 35(45). e2306281–e2306281. 65 indexed citations

14.

Chen, Linfu, Lin Zhang, Rui Zhao, et al.. (2023). Oral delivery of anti-PD-L1 antibody for cancer immunotherapy against orthotopic colorectal tumors. Nano Today. 50. 101834–101834. 22 indexed citations

15.

Shen, Jingjing, Huiqin Gao, Linfu Chen, et al.. (2023). Eyedrop-based macromolecular ophthalmic drug delivery for ocular fundus disease treatment. Science Advances. 9(4). eabq3104–eabq3104. 55 indexed citations

16.

Liu, Nanhui, Junjie Zhu, Wenjun Zhu, et al.. (2023). X‐ray‐Induced Release of Nitric Oxide from Hafnium‐Based Nanoradiosensitizers for Enhanced Radio‐Immunotherapy. Advanced Materials. 35(29). e2302220–e2302220. 77 indexed citations

17.

Chen, Linfu, Rui Zhao, Zhiqin Cao, et al.. (2023). Delivery of short chain fatty acid butyrate to overcome Fusobacterium nucleatum-induced chemoresistance. Journal of Controlled Release. 363. 43–56. 32 indexed citations

18.

Zhou, Jun, Maoyi Li, Qiufang Chen, et al.. (2022). Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery. Nature Communications. 13(1). 3432–3432. 452 indexed citations breakdown →

19.

Hu, Jiaying, Ting Wei, He Zhao, et al.. (2021). Mechanically active adhesive and immune regulative dressings for wound closure. Matter. 4(9). 2985–3000. 99 indexed citations

20.

Fan, Mengni, Jingxing Si, Xiaogang Xu, et al.. (2021). A versatile chitosan nanogel capable of generating AgNPs in-situ and long-acting slow-release of Ag+ for highly efficient antibacterial. Carbohydrate Polymers. 257. 117636–117636. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact